fanapt
Generic: iloperidone
fanapt: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | Approved |
FDA Decisions
Approval1 INDICATIONS AND USAGE FANAPT ® is indicated for: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ]. Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] . FANAPT is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 , 14.1 ) Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. ( 1 , 14.2 )(VNDA)
Frequently asked questions
Who is developing fanapt?
fanapt is being developed by Vanda Pharmaceuticals Inc..
What is fanapt's latest FDA decision?
The most recent tracked FDA decision for fanapt is Approval for 1 INDICATIONS AND USAGE FANAPT ® is indicated for: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ]. Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] . FANAPT is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 , 14.1 ) Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. ( 1 , 14.2 ), dated May 6, 2009.
Get deeper analysis on fanapt
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis